Microbix Biosystems Inc. (MBX.TO)
- GlobeNewswire
Microbix Reports Results for Q3 Fiscal 2022
Q3 Sales of $5.0 million, Q3 Net Earnings of $0.6 millionMISSISSAUGA, Ontario, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and year-to-date fiscal 2022 ended June 30, 2022 (“Q3” and “YTD”), with strong sales and continued positive net earnings, plus ongoing progress upon its strategic goal of increasing its capacity for medical devices production to the
- GlobeNewswire
Microbix Executes Substantial QAPs Supply Agreement
Microbix QAPs to Support Molecular & Antigen Test Platforms for Multiple DiseasesMISSISSAUGA, Ontario, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the execution of a purchase and supply agreement (“Agreement”) by which Microbix “QAPs™” quality assessment products will support assays on industry-leading molecular (PCR) and antigen-based point-of-care testing platforms. QAPs mimic p
- Simply Wall St.
Investors in Microbix Biosystems (TSE:MBX) have made a splendid return of 104% over the past three years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
